Oncology & Cancer

Antibody-guided drug works against acute lymphoblastic leukemia

An antibody packaged with a potent chemotherapy drug to selectively destroy acute lymphoblastic leukemia (ALL) cells eradicated or greatly reduced the disease for 61 percent of 46 patients in a phase II study. It will be ...

Medical research

New thesis on severe COVID-19 and routine biomarker patterns

Anna Sjöström at the research group Experimental and Clinical Neuroendocrinology, the Department of Molecular Medicine and Surgery, will defend her thesis "Severe COVID-19 and routine biomarker patterns" on November 24, ...

Health

Leucocyte amount proportions associate with menopausal stage

The ERMA cohort comprises women aged 47 to 55 years living in the city of Jyväskylä and surrounding municipalities in Finland. The original invitation was posted to 82% of the cohort and 47% answered the invitation. The ...

Oncology & Cancer

Radioimmunotherapy deemed safe and effective for lymphoma patients

A new treatment option for patients with relapsing follicular, mantle cell and other indolent B-cell lymphomas has been determined safe and feasible by researchers exploring the potential of a low energy beta-emitter radiopharmaceutical. ...

page 6 from 7